Empfehlung
21,6
Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
43.2
2 neu, 1 erhöht, 85K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Stammdaten
Unternehmen
| Name | DAXOR CORP |
|---|---|
| Ticker | DXR |
| CIK | 0000027367 |
Branche
| SIC-Code | |
|---|---|
| Beschreibung |
Wertpapier
| CUSIP | 239467103 |
|---|---|
| ISIN | US2394671034 |
| Typ | Common Stock |
| Titel | Daxor Corp |
Status
| Zuletzt geprüft | 2026-03-20 22:22:14.174017 |
|---|
Fondsaktivität (letzte 3 Quartale)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 49,028 | 49,028 | 0 | 723,163 | Unverändert | 0,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 28,221 | 28,921 | -700 | 416,260 | Reduziert | -2,4% | |
| MORGAN STANLEY | 3,237 | 3,537 | -300 | 47,746 | Reduziert | -8,5% | |
| SBI Securities Co., Ltd. | 3,128 | 3,128 | 0 | 46,138 | Unverändert | 0,0% | |
| OSAIC HOLDINGS, INC. | 500 | 0 | 500 | 7,375 | Neu | +100,0% | |
| UBS Group AG | 90 | 0 | 90 | 1,328 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 40 | 0 | 40 | 551 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 5 | 4 | 1 | 74 | Aufgestockt | +25,0% | |
| WELLS FARGO & COMPANY/MN | 0 | 0 | 0 | 2 | Unverändert | 0,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-12-09 | Michel Robert J | Officer, Chief Financial Officer | Open Market Purchase | 3,000 | 12.50 | 37,500.00 | +48,6% | |
| 2025-12-09 | Michel Robert J | Officer, Chief Financial Officer | Open Market Purchase | 3,000 | 12.50 | 37,500.00 | +48,6% | |
| 2025-12-09 | Feldschuh Jonathan Adam | Director, Officer, Chief Scientific Officer | Open Market Purchase | 18,000 | 12.50 | 225,000.00 | +291,5% | |
| 2025-12-09 | Feldschuh Jonathan Adam | Director, Officer, Chief Scientific Officer | Open Market Purchase | 18,000 | 12.50 | 225,000.00 | +291,5% | |
| 2025-11-12 | Jefferies John | Officer, Chief Medical Officer | Open Market Purchase | 2,344 | 12.80 | 30,003.20 | +38,9% | |
| 2025-11-12 | Jefferies John | Officer, Chief Medical Officer | Open Market Purchase | 2,344 | 12.80 | 30,003.20 | +38,9% | |
| 2025-04-04 | Feldschuh Michael Richard | Director, Officer, Chief Executive Officer | Open Market Purchase | 2,063 | 7.89 | 16,277.07 | +21,1% | |
| 2025-04-04 | Feldschuh Michael Richard | Director, Officer, Chief Executive Officer | Open Market Purchase | 2,063 | 7.89 | 16,277.07 | +21,1% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-02-17 | 324 | 12,61 | 4.086 |
Top-Fondshalter (aktuelles Quartal)
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| VANGUARD GROUP INC | 49,028 | 723,163 | 58.22 |
| RENAISSANCE TECHNOLOGIES LLC | 28,221 | 416,260 | 33.51 |
| MORGAN STANLEY | 3,237 | 47,746 | 3.84 |
| SBI Securities Co., Ltd. | 3,128 | 46,138 | 3.71 |
| OSAIC HOLDINGS, INC. | 500 | 7,375 | 0.59 |
| UBS Group AG | 90 | 1,328 | 0.11 |
| JPMORGAN CHASE & CO | 5 | 74 | 0.01 |
| WELLS FARGO & COMPANY/MN | 0 | 2 | 0.00 |